Compare · BTI vs DFTX
BTI vs DFTX
Side-by-side comparison of British American Tobacco Industries p.l.c. (BTI) and Definium Therapeutics Inc. (DFTX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTI and DFTX operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- BTI is the larger of the two at $128.29B, about 53.8x DFTX ($2.39B).
- Over the past year, BTI is up 35.8% and DFTX is up 232.6% - DFTX leads by 196.8 points.
- DFTX has been more active in the news (10 items in the past 4 weeks vs 6 for BTI).
- BTI has more recent analyst coverage (14 ratings vs 4 for DFTX).
PerformanceBTI+35.78%DFTX+232.60%
2025-05-01+0.00%2026-04-30
- Company
- British American Tobacco Industries p.l.c.
- Definium Therapeutics Inc.
- Price
- $58.80+2.37%
- $21.89+6.81%
- Market cap
- $128.29B
- $2.39B
- 1M return
- +0.53%
- +15.85%
- 1Y return
- +35.78%
- +232.60%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 1998
- News (4w)
- 6
- 10
- Recent ratings
- 14
- 4
BTI
British American Tobacco Industries p.l.c.
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour products, tobacco heating products, and modern oral products; combustible products; and traditional oral products, such as Swedish-style snus and American moist snuff. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
Latest BTI
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form SD filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results
Latest DFTX
- Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
- SEC Form DEFA14A filed by Definium Therapeutics Inc.
- SEC Form DEF 14A filed by Definium Therapeutics Inc.
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day
- Definium Therapeutics Announces New Employee Inducement Grants
- Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments
- Stifel initiated coverage on Definium Therapeutics with a new price target
- Piper Sandler initiated coverage on Definium Therapeutics with a new price target
- Definium Therapeutics to Participate at Upcoming Investor Conferences and Events